Finding and Evaluating Generic Market Entry Opportunities
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th […]
Finding and Evaluating Generic Market Entry Opportunities Read Post »
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th […]
Finding and Evaluating Generic Market Entry Opportunities Read Post »
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. shamil.gizatullin@gowlingwlg.com Although it has become harder to obtain
Getting the most out of pharmaceutical patent-term extensions in Russia Read Post »
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch
Switching to DrugPatentWatch Read Post »
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at
Government as the First Investor in Biopharmaceutical Innovation Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris
Get fresh news and insights, drug patent expirations & more…